Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations

Journal of Pharmaceutical Sciences

Volumn 95, Issue 11, 2006, Pages 2380-2392

  Wardrop, J ^a   Law, D ^a   Qiu, Y ^a   Engh, K ^a   Faitsch, L ^a   Ling, C ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Amorphous; Direct compression; Phase transformation; Polarized light microscopy; Stability; Tablet; Wet granulation

Indexed keywords

ABBOTT 232; ALPHA 1A ADRENERGIC RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROSCOPY; SOLID; SPECTROMETRY; TABLET; X RAY DIFFRACTION;

EID: 33750901118     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20679     Document Type: Article

References (19)

1. Yu L. 2001. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev 48:27-42.
2. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91-114.
3. Zhang GGZ, Law D, Schmitt EA, Qiu Y. 2004. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev 56:371-390.
4. Byrn SR, Xu X, Newman A. 2001. Chemical reactivity in solid-state pharmaceuticals: Formulation implications. Adv Drug Deliv Rev 48:115-136.
5. Ward GH, Schultz RH. 1995. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm Res 12: 773-779.
6. Li Y, Worosila GD, Wang W, Mascaro T. 2005. Determination of polymorph conversion of an active pharmaceutical ingredient in wet granulation using NIR Calibration models generated from the premix blends. J Pharm Sci 94:2800-2806.
7. Faitsch L, Wardrop J, Engh K, Vandebruggen B, Qiu Y. 2002. Investigation of extended release single unit matrix and multi-unit reservoir systems for a highly soluble compound, ABT-232. AAPS Annual Meeting, Toronto, Ontario.
8. Matsumoto T, Zografi G. 1999. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res 16:1722-1728.
9. Katzhendler I, Azoury R, Friedman M. 1998. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J Control Release 54:69-85.
10. Kesavan JG, Peck GE. 1996. Solid-state stability of theophylline anhydrous in theophylline anhydrous-polyvinylpyrrolidone physical mixtures. Drug Dev Ind Pharm 22:189-199.
11. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. 2001. Physical stabilization of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Biopharm 12:261-269.
12. Hilden LR, Morris KR. 2003. Prediction of the relaxation behavior of amorphous pharmaceutical compounds. 1. Master curves concept and practice. J Pharm Sci 92:1464-1472.
13. Perng CY, Kearney AS, Patel K, Palepu NR, Zuber G. 1998. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int J Pharm 176:31-38.
14. Pikal MJ, Lukes AL, Lang JE. 1977. Thermal decomposition of amorphous β-lactam antibacterials. J Pharm Sci 66:1312-1316.
15. Saleki-Gerhardt A, Ahlneck C, Zografi G. 1994. Assessment of disorder in crystalline solids. Int J Pharm 101:237-247.
16. Ahlneck C, Zografi G. 1990. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 62:87-95.
17. Shalaev E, Zografi G. 2002. The concept of "structure" in amorphous solids from the perspective of the pharmaceutical sciences. Special Publication-Royal Society of Chemistry, 281 (Amorphous Food and Pharmaceutical Systems), 11-30. ISSN: 0260-6291.
18. Crowley KJ, Zografi G. 2002. Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability. J Pharm Sci 91:492-507.
19. Shakhtshneider TP. 1997. Phase transformations and stabilization of metastable states of molecular crystals under mechanical activation. Solid State Ionics 101-103:851-856.